VistaGen Wins NIH Funding

South San Francisco-based VistaGen Therapeutics, Inc., a biopharmaceutical firm specializing in the use of embryonic stem cell technologies in drug development, was awarded a $1.2 million grant from National Institutes of Health, the company announced Tuesday.

The funding is the final phrase of a $4.3 grant for the development of AV-101, a potential treatment for neuropathic pain, Parkinson’s disease and epilepsy.

Just Posted

BART: busking ban on trains may be legal despite opposition, free speech concerns

When BART board director Debora Allen first floated her proposal to ban… Continue reading

Conservative mayoral candidate defends controversial billboard: ‘this is beautiful art’

Local elected officials denounce depiction of Mayor London Breed as ‘racist’

PG&E warns another round of power shutoffs possible starting Wednesday evening

PG&E Monday afternoon gave a 48-hour notice to approximately 209,000 customers in… Continue reading

SF police union dumps $50K into committee against DA candidate

San Francisco’s police union is preparing to spend big money to defeat… Continue reading

Interim DA Suzy Loftus lays out plans for brief tenure before election day

‘One week matters’: Candidate fends off criticism that appointment was simply politics

Most Read